ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 55 filers reported holding ITEOS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,989,696 | -17.3% | 2,738,785 | 0.0% | 16.06% | -9.7% |
| Q2 2023 | $36,261,513 | -2.7% | 2,738,785 | 0.0% | 17.78% | +14.5% |
| Q1 2023 | $37,274,864 | -30.3% | 2,738,785 | 0.0% | 15.53% | -30.6% |
| Q4 2022 | $53,488,471 | +2.5% | 2,738,785 | 0.0% | 22.38% | +12.6% |
| Q3 2022 | $52,174,000 | -7.5% | 2,738,785 | 0.0% | 19.87% | -16.5% |
| Q2 2022 | $56,419,000 | -36.0% | 2,738,785 | 0.0% | 23.81% | -21.0% |
| Q1 2022 | $88,134,000 | -34.4% | 2,738,785 | -5.1% | 30.12% | +3.8% |
| Q4 2021 | $134,347,000 | +51.2% | 2,885,470 | -12.3% | 29.03% | +41.0% |
| Q3 2021 | $88,849,000 | -5.5% | 3,290,711 | -10.2% | 20.59% | +17.8% |
| Q2 2021 | $94,027,000 | -25.8% | 3,665,787 | -1.1% | 17.48% | -28.6% |
| Q1 2021 | $126,694,000 | +1.1% | 3,706,663 | 0.0% | 24.48% | +38.0% |
| Q4 2020 | $125,359,000 | +37.1% | 3,706,663 | 0.0% | 17.74% | +4.0% |
| Q3 2020 | $91,443,000 | – | 3,706,663 | – | 17.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 3,706,663 | $126,694,000 | 24.48% |
| MPM BioImpact LLC | 2,355,557 | $80,513,000 | 10.12% |
| Boxer Capital, LLC | 4,345,016 | $148,513,000 | 5.04% |
| RA Capital Management | 4,417,258 | $150,982,000 | 2.28% |
| Ally Bridge Group (NY) LLC | 322,794 | $11,033,000 | 2.12% |
| Asymmetry Capital Management, L.P. | 102,286 | $3,496,000 | 1.81% |
| RTW INVESTMENTS, LP | 2,762,791 | $94,432,000 | 1.47% |
| COWEN AND COMPANY, LLC | 588,238 | $20,106,000 | 1.38% |
| Artal Group S.A. | 1,094,047 | $37,395,000 | 0.66% |
| HighVista Strategies LLC | 19,804 | $677,000 | 0.50% |